Clinical trial NCT03103594 - References

Bladder Pain Syndrome — Comparison of the Treatment of Refractory Bladder Pain Syndrome With DMSO and DMSO With Botulinum Toxin A

Citation(s)

•   Birder LA, Kanai AJ, de Groat WC
  DMSO: effect on bladder afferent neurons and nitric oxide release. J Urol. 1997 Nov;158(5):1989-95.
•   Cui Y, Zhou X, Zong H, Yan H, Zhang Y
  The efficacy and safety of onabotulinumtoxinA in treating idiopathic OAB: A systematic review and meta-analysis. Neurourol Urodyn. 2015 Jun;34(5):413-9. doi: 10.1002/nau.22598. Epub 2014 Mar 28. Review.
•   D'Ascanio P, Pompeiano M, Tononi G
  Inhibition of vestibulospinal reflexes during the episodes of postural atonia induced by unilateral lesion of the locus coeruleus in the decerebrate cat. Arch Ital Biol. 1989 Mar;127(2):81-97.
•   Lucioni A, Bales GT, Lotan TL, McGehee DS, Cook SP, Rapp DE
  Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation. BJU Int. 2008 Feb;101(3):366-70. doi: 10.1111/j.1464-410X.2007.07312.x.
•   Smith CP, Radziszewski P, Borkowski A, Somogyi GT, Boone TB, Chancellor MB
  Botulinum toxin a has antinociceptive effects in treating interstitial cystitis. Urology. 2004 Nov;64(5):871-5; discussion 875.
•   Stewart BH, Branson AC, Hewitt CB, Kiser WS, Straffon RA
  The treatment of patients with interstitial cystitis, with special reference to intravesical DMSO. Trans Am Assoc Genitourin Surg. 1971;63:69-74.

Comparison of the Treatment of Refractory Bladder Pain Syndrome With Dimethyl Sulfoxide (DMSO) Alone and DMSO as a Carrier Molecule for Botulinum Toxin A Instillation.

Details for clinical trial NCT03103594